1. Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden Suzuki, Hirosumi, Yamada, Takeshi, Sugaya, Akinori, Ueyama, Shunsuke, Yamamoto, Yoshiyuki, Moriwaki, Toshikazu, Hyodo, Ichinosuke International journal of clinical oncology 26 370 - 377 (2020)
2. Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG Izawa, Naoki, Shitara, Kohei, Yonesaka, Kimio, Yamanaka, Takeharu, Yoshino, Takayuki, Sunakawa, Yu, Masuishi, Toshiki, Denda, Tadamichi, Yamazaki, Kentaro, Moriwaki, Toshikazu, Okuda, Hiroyuki, Kondoh, Chihiro, Nishina, Tomohiro, Makiyama, Akitaka, Baba, Hideo, Yamaguchi, Hironori, Nakamura, Masato, Hyodo, Ichinosuke, Muro, Kei, Nakajima, Takako Eguchi TARGETED ONCOLOGY 15 (5) 623 - 633 (2020)
3. REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer Narita, Yukiya, Shoji, Hirokazu, Kawai, Sadayuki, Mizukami, Takuro, Nakamura, Michio, Moriwaki, Toshikazu, Yamanaka, Takeharu, Sunakawa, Yu, Kawakami, Hisato, Nishina, Tomohiro, Misumi, Toshihiro, Muro, Kei FUTURE ONCOLOGY Epub (2020)
4. Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G) Sakai, Daisuke, Taniguchi, Hiroya, Sugimoto, Naotoshi, Tamura, Takao, Nishina, Tomohiro, Hara, Hiroki, Esaki, Taito, Denda, Tadamichi, Sakamoto, Takeshi, Okuda, Hiroyuki, Satoh, Taroh, Tsushima, Takahiro, Makiyama, Akitaka, Tsuda, Takashi, Hosokawa, Ayumu, Kuramochi, Hidekazu, Tokunaga, Shinya, Moriwaki, Toshikazu, Yasui, Hisateru, Ishida, Hiroyasu, Tsuji, Akihito, Otsu, Satoshi, Shimokawa, Hozumi, Baba, Eishi, Sato, Mikio, Matsumoto, Shigemi, Ozaki, Yukinori, Shinozaki, Katsunori, Tamagawa, Hir EUROPEAN JOURNAL OF CANCER 135 11 - 21 (2020)
5. Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer Kito, Yosuke, Satake, Hironaga, Taniguchi, Hiroya, Yamada, Takeshi, Horie, Yoshiki, Esaki, Taito, Denda, Tadamichi, Yasui, Hisateru, Izawa, Naoki, Masuishi, Toshiki, Moriwaki, Toshikazu, Mori, Keita, Yamazaki, Kentaro Cancer Chemotherapy and Pharmacology 86 (2) 277 - 284 (2020)
6. Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study). Akitaka Makiyama, Yasutaka Sukawa, Tomomi Kashiwada, Junji Kawada, Ayumu Hosokawa, Yoshiki Horie, Akihito Tsuji, Toshikazu Moriwaki, Hiroaki Tanioka, Katsunori Shinozaki, Keita Uchino, Hirofumi Yasui, Hiroshi Tsukuda, Kazuhiro Nishikawa, Hiroyasu Ishida, Takeharu Yamanaka, Kentaro Yamazaki, Shuichi Hironaka, Taito Esaki, Narikazu Boku, Ichinosuke Hyodo, Kei Muro 38 (17) 1919 - 1927 (2020)
7. A case of advanced gastric cancer showing HER2 positivity after chemotherapy Hirose, Suguru, Moriwaki, Toshikazu, Yamaura, Masamichi, Suganuma, Daisuke, Tajima, Hiroki, Sato, Masashi, Enami, Chiaki, Yamada, Takeshi, Yamamoto, Yoshiyuki, Sakamoto, Noriaki, Hyodo, Ichinosuke INTERNATIONAL CANCER CONFERENCE JOURNAL 9 (3) 112 - 115 (2020)
8. Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report Iwata, Narushi, Shikama, Ayumi, Takao, Wataru, Hosokawa, Yoshihiko, Itagaki, Hiroya, Tasaka, Nobutaka, Akiyama, Azusa, Ochi, Hiroyuki, Minaguchi, Takeo, Arita, Miwa, Noguchi, Emiko, Moriwaki, Toshikazu, Satoh, Toyomi BMC medical genetics 21 (1) 76 (2020)
9. Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study. Toshikazu Moriwaki, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Taito Esaki, Akitaka Makiyama, Tadamichi Denda, Yukimasa Hatachi, Takeshi Suto, Naotoshi Sugimoto, Masanobu Enomoto, Toshiaki Ishikawa, Tomomi Kashiwada, Eiji Oki, Yoshito Komatsu, Akihito Tsuji, Kenji Tsuchihashi, Daisuke Sakai, Hideki Ueno, Takao Tamura, Kimihiro Yamashita, Yasuhiro Shimada 25 (4) 614 - 621 (2020)
10. Vascular endothelial growth factor (VEGF)-D and clinical outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with second-line FOLFIRI plus bevacizumab (Bev): A biomarker study of the WJOG 6210G trial Izawa, Naoki, Shitara, Kohei, Masuishi, Toshiki, Denda, Tadamichi, Yamazaki, Kentaro, Moriwaki, Toshikazu, Okuda, Hiroyuki, Kondoh, Chihiro, Nishina, Tomohiro, Makiyama, Akitaka, Baba, Hideo, Yamaguchi, Hironori, Nakamura, Masato, Sunakawa, Yu, Akiyoshi, Kohei, Sato, Mikio, Yonesaka, Kimio, Yoshino, Takayuki, Yamanaka, Takeharu, Muro, Kei JOURNAL OF CLINICAL ONCOLOGY 38 (4::S) (2020)

researchmap の論文リストを表示する Show the publication list on researchmap